Evidence map›Paper›PMID 34890367›Full record

ArticleAging2021

Protective effects of galangin against H

Jian-Jr Lee, Shang-Chuan Ng, Yean-Tin Ni, Jian-Sheng Liu, Chih-Jung Chen, Viswanadha Vijaya Padma, Chih-Yang Huang, Wei-Wen Kuo

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Anti-Photoaging Effects of a Standardized Hot Water Extract ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Nutrients · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Galangin Reverses HInternational journal of molecular sciences · 2022
    Article
  19. Frontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jian-Jr LeeDepartment of Plastic and Reconstructive Surgery, China Medical University Hospital, Taichung 40447, Taiwan, ROC.
Shang-Chuan NgDepartment of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung 406, Taiwan, ROC.
Yean-Tin NiDepartment of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung 406, Taiwan, ROC.
Jian-Sheng LiuDepartment of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung 406, Taiwan, ROC.
Chih-Jung ChenDivision of Breast Surgery, Department of Surgery, China Medical University Hospital, Taichung 40447, Taiwan, ROC.
Viswanadha Vijaya PadmaTranslational Research Laboratory, Department of Biotechnology, School of Biotechnology and Genetic Engineering, Bharathiar University, Coimbatore 641046, Tamil Nadu, India.
Chih-Yang HuangCardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan, ROC.
Wei-Wen KuoDepartment of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung 406, Taiwan, ROC.
China Medical University · TWBharathiar University · INChina Medical University Hospital · TWTzu Chi University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the mechanism underlying the protective effects of galangin against H

Indexed as

Signal TransductionCollagenFibroblastsFlavonoidsHumansHydrogen PeroxideMicroRNAsRadiation-Protective AgentsSkinSkin AgingSmad ProteinsTransforming Growth Factor betaUltraviolet RaysCollagenFlavonoidsgalanginHydrogen PeroxideMicroRNAsMIRN4535 microRNA, humanRadiation-Protective AgentsSmad ProteinsTransforming Growth Factor betagalanginH2O2hsa-miR-4535Smad4UVB

Identifiers

PMID34890367
PMCPMC8714160
OpenAlexW4200025500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.